Interface-Based Design of High-Affinity Affibody Ligands for the Purification of RBD from Spike Proteins
Description
The outbreak of coronavirus disease 2019 (COVID-19) has sparked an urgent demand for advanced diagnosis and vaccination worldwide. The discovery of high-affinity ligands is of great significance for vaccine and diagnostic reagent manufacturing
